Innovotech Competitors

Quest PharmaTech (CVE:QPT) and Innovotech (CVE:IOT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Valuation & Earnings

This table compares Quest PharmaTech and Innovotech's revenue, earnings per share and valuation.

Quest PharmaTech has higher earnings, but lower revenue than Innovotech. Quest PharmaTech is trading at a lower price-to-earnings ratio than Innovotech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Quest PharmaTech and Innovotech's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Quest PharmaTech and Innovotech, as provided by MarketBeat.com.

Summary

Quest PharmaTech beats Innovotech on 3 of the 5 factors compared between the two stocks.

Ceapro (CVE:CZO) and Innovotech (CVE:IOT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, risk, analyst recommendations, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Ceapro and Innovotech, as reported by MarketBeat.com.

Profitability

This table compares Ceapro and Innovotech's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Ceapro and Innovotech's top-line revenue, earnings per share (EPS) and valuation.

Ceapro has higher revenue and earnings than Innovotech. Ceapro is trading at a lower price-to-earnings ratio than Innovotech, indicating that it is currently the more affordable of the two stocks.

Summary

Ceapro beats Innovotech on 3 of the 5 factors compared between the two stocks.

Crescita Therapeutics (TSE:CTX) and Innovotech (CVE:IOT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Earnings & Valuation

This table compares Crescita Therapeutics and Innovotech's revenue, earnings per share (EPS) and valuation.

Innovotech has lower revenue, but higher earnings than Crescita Therapeutics. Innovotech is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Crescita Therapeutics and Innovotech, as provided by MarketBeat.

Profitability

This table compares Crescita Therapeutics and Innovotech's net margins, return on equity and return on assets.

Innovotech (CVE:IOT) and Kane Biotech (CVE:KNE) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations and valuation.

Earnings and Valuation

This table compares Innovotech and Kane Biotech's top-line revenue, earnings per share and valuation.

Innovotech has higher earnings, but lower revenue than Kane Biotech. Kane Biotech is trading at a lower price-to-earnings ratio than Innovotech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Innovotech and Kane Biotech's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings for Innovotech and Kane Biotech, as reported by MarketBeat.com.

Summary

Innovotech beats Kane Biotech on 3 of the 5 factors compared between the two stocks.

Innovotech (CVE:IOT) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Innovotech and Devonian Health Group, as provided by MarketBeat.com.

Profitability

This table compares Innovotech and Devonian Health Group's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Innovotech and Devonian Health Group's gross revenue, earnings per share (EPS) and valuation.

Innovotech has higher earnings, but lower revenue than Devonian Health Group. Devonian Health Group is trading at a lower price-to-earnings ratio than Innovotech, indicating that it is currently the more affordable of the two stocks.

Summary

Innovotech beats Devonian Health Group on 3 of the 5 factors compared between the two stocks.

Pascal Biosciences (CVE:PAS) and Innovotech (CVE:IOT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of recent recommendations for Pascal Biosciences and Innovotech, as reported by MarketBeat.com.

Profitability

This table compares Pascal Biosciences and Innovotech's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Pascal Biosciences and Innovotech's revenue, earnings per share (EPS) and valuation.

Innovotech has higher revenue and earnings than Pascal Biosciences. Pascal Biosciences is trading at a lower price-to-earnings ratio than Innovotech, indicating that it is currently the more affordable of the two stocks.

Summary

Innovotech beats Pascal Biosciences on 3 of the 3 factors compared between the two stocks.